You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,326.0% | -2,116.7% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 106.4 | 154.6 |
| Price / Book value | 3.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 27.7% | -83.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 4.7% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-04-30 | 0.36 | -5.43 | -8.69p | -7.8 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.58 | -7.73 | -5.69p | -11.0 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.59 | -12.49 | -5.70p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 2.16 | -21.83 | -8.55p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Angle looks to raise up £20.0m via conditional placing Sharecast News | 27 Oct |
|---|---|
| FDA accepts Angle's review submission for Parsortix PC1 Sharecast News | 20 Oct |
| Angle's Parsortix displays potential use for detection of immunotherapy efficacy Sharecast News | 14 Aug |
| Holding(s) in Company | 20-Nov-20 16:19 |
|---|---|
| Holding(s) in Company | 18-Nov-20 16:52 |
| Result of General Meeting | 13-Nov-20 10:47 |
| Director/PDMR Shareholding | 03-Nov-20 14:55 |
| Interim Results | 29-Oct-20 07:05 |